Related Experiment Video
Updated: Jul 27, 2025

Network Pharmacology and Validation of the Antidepressant Mechanisms of Qiangzhifang in a Chronic Restraint Stress-induced Depression Rat Model
Published on: June 6, 2025
Potential Mechanisms Underlying the Therapeutic Roles of
Jinlong Zhao1,2,3, Guihong Liang1,2,3, Hetao Huang2
1The Second Clinical College of Guangzhou University of Chinese Medicine, Guangzhou, 510405, China.
Gancao Fuzi decoction (GFD) treats knee osteoarthritis (KOA) through multiple components and targets, primarily by modulating inflammatory pathways. This study elucidates GFD's complex mechanism for treating cold-dampness obstruction-type KOA.
Area of Science:
- Traditional Chinese Medicine
- Network Pharmacology
- Osteoarthritis Research
Background:
- Knee osteoarthritis (KOA) treatment with Gancao Fuzi decoction (GFD) lacks clarity on active components and molecular mechanisms.
- Understanding GFD's action in cold-dampness obstruction-type KOA is crucial for optimizing therapeutic strategies.
Purpose of the Study:
- To investigate the underlying mechanism of Gancao Fuzi decoction (GFD) in treating cold-dampness obstruction syndrome-type knee osteoarthritis (KOA).
- To utilize network pharmacology to elucidate the multi-component, multi-target interactions of GFD in KOA treatment.
Main Methods:
- Screened active components and targets of GFD herbs (Fuzi, Guizhi, Baizhu, Gancao) using the Traditional Chinese Medicine Systems Pharmacology (TCMSP) database.
- Identified KOA targets from databases like CTD, GeneCards, and DisGeNET to find common drug-disease targets.
- Constructed active component-target and protein-protein interaction networks using Cytoscape and STRING, followed by GO and KEGG pathway enrichment analysis via DAVID.
Main Results:
- Identified 102 potential active components and 208 targets associated with GFD treatment for cold-dampness obstruction syndrome-type KOA.
- GFD's therapeutic effect on KOA is strongly linked to the modulation of numerous inflammatory signaling pathways.
- Network analysis revealed a complex interplay of components and targets, highlighting GFD's holistic approach.
Conclusions:
- Gancao Fuzi decoction (GFD) exerts its therapeutic effects on cold-dampness obstruction syndrome-type knee osteoarthritis (KOA) through a complex mechanism involving multiple components, targets, and pathways.
- The findings provide a foundation for further experimental validation of GFD's pharmacodynamic basis and mechanism of action.
- This study supports the intricate and multi-faceted nature of Traditional Chinese Medicine in treating complex conditions like KOA.
More Related Videos
11:44Cellular Membrane Affinity Chromatography Columns to Identify Specialized Plant Metabolites Interacting with Immobilized Tropomyosin Kinase Receptor B
Published on: January 19, 2022
12:24Mimicking the Function of Signaling Proteins: Toward Artificial Signal Transduction Therapy
Published on: September 29, 2016
Related Concept Videos
Principles of Drug Action
Drugs can be agonists or antagonists. Like the endogenous ligands, agonists always bind and activate the target to produce a cellular response. Agonist binding induces a conformational change which in turn...
Neurochemical Transmission: Sites of Drug Action
Elements Crucial for Effective Psychotherapy
The Therapeutic Alliance
The therapeutic alliance refers to the relationship between the therapist and the client. The alliance strengthens when the therapist and the client engage in a nurturing, supportive, trusting, empathetic, and respectful relationship, improving therapeutic outcomes. Therapists must monitor this relationship...
Transducer Mechanism: Enzyme-Linked Receptors
Major types that are helpful drug targets include:
Targets for Drug Action: Overview
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Drugs Affecting Neurotransmitter Synthesis